\-\ Texto\\:\\ \ \(0\)\
\-\ altered\\ mental\\ status\\.\ \(8\)\
\-\ ascites\ \(66\)\
\-\ splenomegaly\ \(46\)\
\-\ elevated\\ bilirubin\ \(3\)\
\-\ awaiting\\ liver\\ transplant\ \(2\)\
\-\ \\â\\€\\¢\\ high\\ signal\\ intensity\\ changes\\ in\\ the\\ globus\\ pallidus\\ \\-\\ bilateral\\,\\ cerebral\\ peduncles\\,\\ and\\ centrum\\ semiovale\\ ont1\\,\\ t2\\ and\\ flair\ \(0\)\
\-\ \\â\\€\\¢\\ splenomegaly\ \(0\)\
\-\ \\â\\€\\¢\\ cirrhosis\\ of\\ liver\\ and\\ vascular\\ changes\\ of\\ portal\\ hypertension\ \(0\)\
\-\ hepatic\\ encephalopathy\\ w\\/globus\\ pallidus\\ hyperintensity\ \(0\)\
\-\ carbon\\ monoxide\\ exposure\ \(2\)\
\-\ prior\\ manganese\\ exposure\ \(0\)\
\-\ liver\\ failure\ \(5\)\
\-\ tpn\\ \\(total\\ parenteral\\ nutrition\\)\ \(0\)\
\-\ 56\\ year\\ old\\ woman\\ with\\ a\\ 6\\ year\\ history\\ of\\ chronic\\ hepatitis\\.\\ \\ recent\\ decompensation\\ and\\ now\\ on\\ transplant\\ list\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pallidus\\:\\ 0\\.30085929727792254\ \(0\)\
\-\ globus\\:\\ 0\\.28320312007021475\ \(0\)\
\-\ splenomegaly\\:\\ 0\\.26921664641713144\ \(0\)\
\-\ liver\\:\\ 0\\.23940915267535479\ \(0\)\
\-\ transplant\\:\\ 0\\.23138215961870684\ \(0\)\
\-\ exposure\\:\\ 0\\.21988055674172868\ \(0\)\
\-\ ont1\\:\\ 0\\.1850013060067473\ \(0\)\
\-\ manganese\\:\\ 0\\.1767786243941802\ \(0\)\
\-\ decompensation\\:\\ 0\\.1627218573323087\ \(0\)\
\-\ semiovale\\:\\ 0\\.15959573886925668\ \(0\)\
\-\ centrum\\:\\ 0\\.15449917571974156\ \(0\)\
\-\ parenteral\\:\\ 0\\.15236250364250062\ \(0\)\
\-\ tpn\\:\\ 0\\.1470418539242121\ \(0\)\
\-\ peduncles\\:\\ 0\\.14553897180738518\ \(0\)\
\-\ monoxide\\:\\ 0\\.1441398220299335\ \(0\)\
\-\ changes\\:\\ 0\\.13982721012047464\ \(0\)\
\-\ carbon\\:\\ 0\\.13934594551642734\ \(0\)\
\-\ nutrition\\:\\ 0\\.13934594551642734\ \(0\)\
\-\ awaiting\\:\\ 0\\.1363728815770898\ \(0\)\
\-\ list\\:\\ 0\\.12815019996452265\ \(0\)\
\-\ bilirubin\\:\\ 0\\.12424896951875763\ \(0\)\
\-\ cirrhosis\\:\\ 0\\.12186037335549488\ \(0\)\
\-\ encephalopathy\\:\\ 0\\.12186037335549488\ \(0\)\
\-\ ascites\\:\\ 0\\.11932211136066877\ \(0\)\
\-\ hepatitis\\:\\ 0\\.1189283198004691\ \(0\)\
\-\ altered\\:\\ 0\\.1174254376836422\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.11536132249285583\ \(0\)\
\-\ portal\\:\\ 0\\.11070563818790198\ \(0\)\
\-\ 56\\:\\ 0\\.10803019667475028\ \(0\)\
\-\ mental\\:\\ 0\\.10081976035779414\ \(0\)\
\-\ flair\\:\\ 0\\.09841342949455453\ \(0\)\
\-\ and\\:\\ 0\\.09561738819788437\ \(0\)\
\-\ total\\:\\ 0\\.09478704816755011\ \(0\)\
\-\ hepatic\\:\\ 0\\.09212360288552675\ \(0\)\
\-\ hypertension\\:\\ 0\\.08851304030201637\ \(0\)\
\-\ failure\\:\\ 0\\.0878284308828673\ \(0\)\
\-\ intensity\\:\\ 0\\.08214214139945433\ \(0\)\
\-\ status\\:\\ 0\\.08073028110567862\ \(0\)\
\-\ cerebral\\:\\ 0\\.08014581332960381\ \(0\)\
\-\ now\\:\\ 0\\.07941034872634425\ \(0\)\
\-\ elevated\\:\\ 0\\.0788622173014401\ \(0\)\
\-\ recent\\:\\ 0\\.07832851207535244\ \(0\)\
\-\ vascular\\:\\ 0\\.07637172830428038\ \(0\)\
\-\ year\\:\\ 0\\.07130206240737848\ \(0\)\
\-\ chronic\\:\\ 0\\.06866575306673763\ \(0\)\
\-\ of\\:\\ 0\\.06791558782100633\ \(0\)\
\-\ t2\\:\\ 0\\.06655526514824221\ \(0\)\
\-\ high\\:\\ 0\\.06574628382991343\ \(0\)\
\-\ signal\\:\\ 0\\.0655770509023644\ \(0\)\
\-\ prior\\:\\ 0\\.06472449353273096\ \(0\)\
\-\ bilateral\\:\\ 0\\.062171978548119775\ \(0\)\
\-\ woman\\:\\ 0\\.06024776052432389\ \(0\)\
\-\ history\\:\\ 0\\.04419736520331359\ \(0\)\
\-\ on\\:\\ 0\\.034938063709803874\ \(0\)\
\-\ old\\:\\ 0\\.03423733086625197\ \(0\)\
\-\ in\\:\\ 0\\.02877802119289476\ \(0\)\
\-\ the\\:\\ 0\\.02308282605605047\ \(0\)\
\-\ with\\:\\ 0\\.022652055789515332\ \(0\)\
